Quick Answer
Prime Medicine, Inc. reported Total Assets of $342.73 million for fiscal year 2025.
Prime Medicine, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $342.73M | +15.2% |
| 2024 | $297.51M | +53.5% |
| 2023 | $193.85M | -46.2% |
| 2022 | $360.31M | +19.4% |
| 2021 | $301.86M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $385.01M | +15.7% | +38.0% |
| June 30, 2025 | $279.01M | +7.4% | -15.0% |
| March 31, 2025 | $328.16M | +5.4% | +10.3% |
| December 31, 2024 | $297.51M | +53.5% | -10.6% |
| September 30, 2024 | $332.78M | +39.2% | +28.1% |
| June 30, 2024 | $259.70M | -7.5% | -16.6% |
| March 31, 2024 | $311.38M | -1.8% | +60.6% |
| December 31, 2023 | $193.85M | -46.2% | -18.9% |
- Prime Medicine, Inc. showed an increase of +15.2% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Prime Medicine, Inc.’s total assets has grown by 13.5% (from $301.86 million to $342.73 million).
- The most recent figure is from Prime Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: